Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Accumulated Expenses (2025 - 2026)

Cannabis Bioscience International Holdings' Accumulated Expenses history spans 2 years, with the latest figure at $26773.0 for Q1 2026.

  • On a quarterly basis, Accumulated Expenses changed N/A to $26773.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $26773.0, a N/A change, with the full-year FY2025 number at $22095.0, changed N/A from a year prior.
  • Accumulated Expenses hit $26773.0 in Q1 2026 for Cannabis Bioscience International Holdings, roughly flat from $26773.0 in the prior quarter.
  • Over the last five years, Accumulated Expenses for CBIH hit a ceiling of $26773.0 in Q4 2025 and a floor of $22095.0 in Q2 2025.